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Prions Are Amyloids
Prions are self-propagating amyloids. Amyloids are protein
polymers with a cross-b structure, in which short b-strands from
the monomers stack one on top of each other to make up a fibrillar
polymer [1,2]. These amyloids act as templates that convert
monomers to the amyloid polymerised state. Spontaneous or
chaperone-assisted fragmentation of this amyloid fibril allows
multiplication of the prion particle by generating novel fibril ends
where templating occurs.
Prions have initially been identified in the context of mamma-
lian spongiform encephalopathies such as scrapie in sheep,
Creutzfeld-Jacob disease in humans, or bovine spongiform
encephalopathy (BSE) in cattle [3]. In these diseases, the host
encoded GPI-anchored PrP prion protein turns into prion
aggregates, leading to incurable lethal neurodegenerative diseases.
The prion phenomenon is not restricted to this sole example. In
particular, nine prion proteins have been identified in yeast and
correspond to proteins with a wide range of cellular functions [4].
Generally, prion formation leads to loss of the cellular function of
the protein. Yeast prions are thus detected as non-Mendelian
genetic elements, leading to infectious and inheritable protein
inactivation.
More than 30 human diseases, including Alzheimer disease, are
caused by accumulation of amyloid aggregates of various proteins
and peptides in the brain or systemic locations [2]. Many proteins
can form amyloids, and the amyloid fold has been envisioned as a
default conformational state that is formed when the native state of
the protein cannot be efficiently attained or maintained. This view
is, for instance, illustrated by the finding that inclusion bodies
formed during recombinant protein over-expression in E. coli have
an amyloid-like structure [5]. But in nature, the amyloid fold is not
only found in abnormal or pathological situations. The specific
physico-chemical properties of this fold have also been exploited to
perform various biological functions. Amyloids constitute various
cell surface structures in bacteria, fungi, and insects. Amyloids
allow storage and delayed release of various peptide hormones in
mammals [6]. Then, it has been proposed that this ability of a
protein to exist under two states (a functional and a self-
inactivating form) represents an epigenetic mechanism of gene
regulation [7]. In that perspective, yeast prions have been
suggested to represent a benefit [8], but this view remains debated
[9].
The [Het-s] Prion Has a Role in Non-Self
Recognition
[Het-s] is a prion of the filamentous fungus Podospora anserina and
is involved in a non-self recognition process termed heterokaryon
incompatibility [10]. In filamentous fungi, cell fusions between
different strains occur spontaneously and lead to the formation of
heterokaryons, containing nuclei from both fusion partners. Yet,
almost invariably, these heterokaryotic cells undergo cell death
soon after fusion. This rejection of non-self is due to genetic
differences between the fusion partners at certain specific loci
designated het loci. The biological significance of incompatibility is
not fully understood. Incompatibility could serve to limit the
cytoplasmic mixing between unlike individuals to restrict trans-
mission of mycoviruses between strains or to prevent conspeficic
parasitism of one nuclear type by another. It has also been
proposed that incompatibility in fungi could represent an
evolutionary by-product of pathogen-driven divergence in genes
whose primary function lies in host defense against microbial
pathogens [11]. In this view, het genes were identified because they
cause rejection of conspecific non-self, but their original function
lies in the recognition of heterospecific non-self, a situation
analogous to the MHC complex in mammals.
Nine het loci have been identified in Podospora anserina and het-s,
the gene encoding the [Het-s] prion is one of them. The het-s locus
has two alternative incompatible alleles, het-s and het-S. When a het-
s strain fuses with a het-S strain, the fusion cell undergoes cell
death. But this cell death reaction only occurs when the HET-s
protein is in the prion conformation. In other words, [Het-s]
prion-infected strains are incompatible with het-S, while prion-free
strains (designated [Het-s*]) are compatible with het-S. The [Het-s]
prion is transmitted from one strain to another after cell fusion and
is transmitted from the maternal parent to the meiotic progeny
[10].
The Structure of the HET-s Prion Forming Domain
Is Well Defined and Conserved in Evolution
The HET-s prion protein contains two distinct domains: an N-
terminal a-helical globular domain designated HeLo and the C-
terminal prion forming domain (PFD), which is necessary and
sufficient for prion propagation and amyloid formation [12,13].
This domain is natively unfolded in the soluble conformation of
the protein.
The structure of the HET-s PFD in its prion conformation was
solved by solid state NMR [14]. The PFD adopts a b-solenoid
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triangular hydrophobic core. This structure is exceptionally well
resolved and organised, in contrast to many other amyloid
proteins, which often exist as a mixture of structural variants. A
number of HET-s orthologs have been identified in other
pezizomycotina fungi, and sequence comparisons and functional
studies reveal a conservation of key residues, critical for formation
of the b-solenoid fold, and indicate a selective pressure for the
maintenance of the ability to form that specific amyloid fold
[15,16].
HET-s Is the Trigger for Activation of the HET-S
Toxicity Domain
The HET-s and HET-S proteins differ by 13 residues, and the
HET-S protein displays the same two-domain organisation as
HET-s. The HET-s and HET-S PFD regions are functionally
equivalent and interchangeable; the functional difference between
HET-s and HET-S is determined by the amino acid differences in
their HeLo domains [12]. The HeLo domain of HET-S represents
the cell death execution domain in the het-s/het-S system. It is
proposed that in the incompatibility reaction, the prion form of
HET-s interacts with the PFD region of HET-S, and the
conversion of the HET-S PFD region into the b-solenoid fold
induces a conformational change in the HeLo domain, leading to
its activation and triggering of cell death by incompatibility
(Figure 1) [13]. Upon interaction with [Het-s], HET-S relocates to
the cell periphery and this cell periphery localisation correlates
with cell death [17]. In contrast, the HeLo domain of HET-s does
not exert any toxicity. Thus, in the incompatibility reaction, HET-
s and HET-S do not have equivalent roles, the HET-S HeLo
domain represents the cell death execution entity, and the prion
form of [Het-s] acts as a trigger for activation of this toxicity
domain. Sequence analyses suggest that het-s-homologs in other
fungal species are actually HET-S rather than HET-s homologs.
NWD2 as a Functional Partner of HET-S
Recently, a potential additional functional partner of HET-S
was identified. A search for proteins displaying homology to the
HET-s PFD led to the identification of a protein termed NWD2
encoded by the gene immediately adjacent to het-S [18]. NWD2 is
part of an NWD gene family comprising other het genes. NWD
proteins are STAND proteins resembling Nod-like receptors and
are thought to represent the fungal counterparts of pathogen
recognition receptors described in plants and metazoans [19].
STAND proteins are signal transducing NTPases that undergo
ligand-induced oligomerisation. They typically display three
domains: a central nucleotide-binding oligomerisation domain
(NOD) flanked by a C-terminal ligand-binding domain and an N-
terminal effector domain. NWD2 lacks a defined effector domain
and in its place displays at the N-terminal end a short region of
homology with the elementary HET-s repeat motif [18]. Based on
homology modelling, this region is predicted to adopt the b-
solenoid fold. A model postulating the existence of a functional
interaction between NWD2 and HET-S was proposed [18]. In
that model, NWD2 recognises a ligand via its C-terminal WD-40
repeat domain and oligomerises in response to this binding. This
Figure 1. Two proposed mode of activation of the HeLo toxicity domain of HET-S. The current model envisioned for activation of the HeLo
toxicity domain of HET-S is depicted. Upon prion formation, the C-terminal HET-s prion forming domain (PFD) adopts the b-solenoid amyloid fold.
The b-solenoid fold of HET-s then serves as a template to transconform the corresponding region in the HET-S protein. Refolding of the HET-S PFD
region leads to a refolding of the globular HeLo domain, and this refolding renders the protein toxic. The NWD2 protein displays three domains: an N-
terminal motif homologous to the HET-s PFD, a central NACHT oligomerisation domain, and a C-terminal WD-repeat domain (WD). It is proposed that
upon binding of a ligand (L), NWD2 undergoes oligomerisation and that this oligomerisation allows the N-terminal region of the NWD2 protein to
adopt a HET-s-like b-solenoid fold. This N-terminal extension would then lead to templating and activation of the HET-S HeLo domain (in a way
analogous to [Het-s]).
doi:10.1371/journal.ppat.1002687.g001
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NWD2 proteins into close proximity and allow their cooperative
folding into the b-solenoid fold. Once formed, this fold would be
used as a template for transconformation of the HET-S PFD and
activation of the HeLo toxicity domain. Thus, two modes of
activation of the HET-S HeLo domain are now envisioned, either
by interaction with the prion form of HET-s (as occurs during
incompatibility) or by interaction with the oligomeric form of
NWD2 (Figure 1).
This model postulates the existence of a mechanism of signal
transduction STAND proteins where oligomerisation of a STAND
protein induces formation of an amyloid-like fold in a short region
N-terminal to the NOD domain. This amyloid-fold would in turn
trigger transconformation of the protein responsible for the
execution of the cell death reaction. Fungal genome analyses
suggest that this mode of interaction between STAND signal
transducing proteins and prion or prion-like proteins is not an
isolated occurrence [18]. Several other analogous systems were
identified in genome searches, suggesting that this mode of
activation of effector domains is both widespread and evolution-
arily conserved in fungi. What is emerging is the notion that
transmission of an amyloid fold can be used as integrated part of a
signal transduction pathway.
In the end, the focus needs to be redirected from [Het-s] to
HET-S. [Het-s] turns out to be but a trigger to activate the HeLo
toxicity domain of HET-S. HET-S is actually doing the job and
represents the central player in the system. It will be of interest to
elucidate the actual mechanism of toxicity that is associated with
relocalisation of HET-S to the cell membrane. Other current
questions regarding this system deal with the biological meaning of
NWD2/HET-S pathway: what is the ligand recognised by
NWD2, and what is the purpose of the HET-S-induced cell
death reaction in response to this ligand binding?
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